Bone Biologics Corp (BBLG)
1.52
-0.01
(-0.33%)
USD |
NASDAQ |
Apr 25, 16:00
1.56
+0.04
(+2.63%)
After-Hours: 20:00
Bone Biologics Total Liabilities (Quarterly): 0.8314M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.8314M |
| September 30, 2023 | 1.183M |
| June 30, 2023 | 1.930M |
| March 31, 2023 | 4.011M |
| December 31, 2022 | 2.548M |
| September 30, 2022 | 0.7995M |
| June 30, 2022 | 0.0706M |
| March 31, 2022 | 0.0549M |
| December 31, 2021 | 0.0999M |
| September 30, 2021 | 15.18M |
| June 30, 2021 | 14.62M |
| March 31, 2021 | 14.20M |
| December 31, 2020 | 13.69M |
| September 30, 2020 | 13.24M |
| June 30, 2020 | 12.85M |
| March 31, 2020 | 12.47M |
| December 31, 2019 | 11.90M |
| Date | Value |
|---|---|
| September 30, 2019 | 11.63M |
| June 30, 2019 | 11.12M |
| March 31, 2019 | 10.79M |
| December 31, 2018 | 9.639M |
| September 30, 2018 | 9.525M |
| June 30, 2018 | 9.834M |
| March 31, 2018 | 9.005M |
| December 31, 2017 | 9.192M |
| September 30, 2017 | 12.84M |
| June 30, 2017 | 11.39M |
| March 31, 2017 | 10.24M |
| December 31, 2016 | 9.065M |
| September 30, 2016 | 8.123M |
| June 30, 2016 | 7.950M |
| March 31, 2016 | 7.634M |
| December 31, 2015 | 7.228M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.0549M
Minimum
Mar 2022
15.18M
Maximum
Sep 2021
7.496M
Average
11.12M
Median
Jun 2019
Total Liabilities (Quarterly) Benchmarks
| BioVie Inc | 14.00M |
| Krystal Biotech Inc | 39.71M |
| Adial Pharmaceuticals Inc | 0.6531M |
| Processa Pharmaceuticals Inc | 0.7975M |
| Calidi Biotherapeutics Inc | 18.25M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.738M |
| Shareholders Equity (Quarterly) | 2.906M |